Telomir Pharmaceuticals, Inc. (TELO) stock
TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.49−0.01 (-1.96%)
Close on Nov 13, 2026Market cap $33.74MP/E –Yield –
Telomir Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Telomir Pharmaceuticals's enterprise value was $35.75M on Nov 11, 2026, against $38.00M a year earlier. Over the last 3 years it ranged from $31.24M to $259.49M, with a median of $71.86M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $35.75M | -5.1% |
| 2025 | Dec 31, 2025 | $37.67M | -68.9% |
| 2024 | Dec 31, 2024 | $121.16M | – |
See a number that looks wrong?